Pfizer Animal Health begins integration with Alpharma

With the acquisition of King Pharmaceuticals by Pfizer, Inc, announced on February 28, Pfizer Animal Health will begin integrating Alpharma, LLC into its existing business.

The integration of Alpharma allows Pfizer Animal Health to build on its already broad product portfolio of biologics, medicines and immuno-diagnostics. “Pfizer Animal Health welcomes Alpharma colleagues and the company’s respected products and services,” said Clint Lewis, President of U.S. Operations for Pfizer Animal Health.

“Today marks another important milestone in Pfizer Animal Health’s evolution in offering veterinarians, nutritionists and all our customers a more comprehensive portfolio of unique products and services. It also further demonstrates our commitment to becoming a complete solutions provider for our customers.”

This blog is written by Martin Little The Global Miller, published and supported by the GFMT Magazine from Perendale Publishers.